End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
960 MAD | +0.73% |
|
-4.00% | +0.95% |
Business Summary
- drug sales: products made under license and under own names;
- importing and sales of drugs, dental products, and ophthalmic equipment;
- subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories.
At the end of 2019, Sothema had 6 production units located in Morocco.
Sales per Business
MAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Licensed Medicines Goods
55.0
%
| 1,262 | 54.8 % | 1,367 | 55.0 % | +8.36% |
Licensed Medicines Merchandise in Morocco
40.4
%
| 915 | 39.7 % | 1,004 | 40.4 % | +9.76% |
Licensed Medicines Goods and Services
4.6
%
| 126 | 5.5 % | 115 | 4.6 % | -8.40% |
Sales per region
MAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Africa
94.3
%
| 2,187 | 95.0 % | 2,345 | 94.3 % | +7.24% |
Europe
3.2
%
| 75 | 3.3 % | 78 | 3.2 % | +4.59% |
Middle East
2.0
%
| 23 | 1.0 % | 50 | 2.0 % | +113.46% |
America
0.5
%
| 17 | 0.7 % | 13 | 0.5 % | -22.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lamia Tazi
CEO | Chief Executive Officer | 47 | 05/10/97 |
Adnane Hilal
DFI | Director of Finance/CFO | - | - |
Mehdi Zaghloul
COO | Chief Operating Officer | - | - |
Taoufik Agoumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Najib Bnana
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/88 |
Ouadie El Euldj
SAM | Sales & Marketing | - | - |
Mounir Haritane
AUD | Comptroller/Controller/Auditor | - | - |
Ouhmani Youssef
HRO | Human Resources Officer | - | - |
Sales & Marketing | - | - | |
Naima El-Haili
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mohamed Tazi
BRD | Director/Board Member | - | - |
Bahia Berrada
BRD | Director/Board Member | - | - |
Karim Berrada
BRD | Director/Board Member | - | 28/06/06 |
Director/Board Member | 54 | - | |
Lamia Tazi
CEO | Chief Executive Officer | 47 | 05/10/97 |
Mohammed Diouri
BRD | Director/Board Member | - | 03/06/09 |
Director/Board Member | - | - | |
Mohamed Ali Tazi
BRD | Director/Board Member | - | - |
Selma Tazi
BRD | Director/Board Member | - | - |
El Ghali Tahiri
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,200,000 | 768,960 ( 10.68 %) | 0 | 10.68 % |
Company contact information
![address Societe de Therapeutique Marocaine S.A.(SOT)](https://cdn.zonebourse.com/static/address/15309954.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.95% | 693M | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- SOT Stock
- Company Societe de Therapeutique Marocaine S.A.